News Items

Health Canada response to our safety concerns over approval of generic "Diclectin"

The SOGC recently wrote to Health Canada to voice our concern about the recent approval of a generic “Diclectin” (doxylamine-pyridoxine).

In response to our letter, Health Canada has reassured us that they stand by the safety of the generic product. Health Canada also reassured us that they will continue to monitor the safety of mannitol and the safety of all health products, including those indicated for use by pregnant women.

As an organization that advocates for patient safety and evidence-based research, we believe pregnancy-specific test is best practice. However, we have accepted the reassurance of Health Canada.